Active, not recruiting
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
NCT06014255
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Northewestern University Chicago, Illinois, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- University of Minnesota Minneapolis, Minnesota, United States
- Mayo Clinic Rochester, Minnesota, United States